Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1992-01-31
1994-12-13
Walsh, Stephen G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
530326, 530806, 530810, 930 10, A61K 37547, C07K 708, C07K 1702
Patent
active
053728092
ABSTRACT:
A family of metalloproteinases exist which cleave extracellular matrix molecules. These metalloproteinases are secreted in a latent inactive form and require activation in order to specifically cleave the preferred substrate. A series of peptides have been prepared based on the complete sequence analysis of type IV procollagenase. Peptide inhibitors were synthesized which correspond to cysteine repeat regions and histidine containing regions; the mechanism of action of these peptides involves inhibition of binding of the enzyme to the substrate. Peptide inhibitors were synthesized which correspond to the peptide cleaved off during activation, and constitute a novel class of metalloproteinase inhibitors. These inhibitors are members of a series of peptides which contain the core amino acid sequence RKPRC or analogs thereof. The cysteine residue is required for activity. Affinity purified antibodies directed against specific peptides can be used to a) detect any general metalloproteinase enzyme with the sequence in part VAAHE or PRCGNPD, and distinguish it from other known members of the metalloproteinase family, b) block functional domains resulting in the inhibition of enzyme activity, and c) distinguish latent from activated forms of the enzyme.
REFERENCES:
patent: 4677058 (1987-06-01), Tryggvason et al.
patent: 4923818 (1990-05-01), Goldberg et al.
Murphy et al. (1985) Biochim. Biophys. Acta. 831:49-58.
Hoyhtga et al. (1988, Jun.) FEBs Lett. 233 (1):109-113.
Knauper et al. (1990, Apr.) Eur. J. Biochem. 189:295-300.
Stetler-Stevenson et al. (1989, Jan. 25) J. Biol. Chem. 264(3):1353-1356.
Collier et al. (1988, May 15) J. Biol. Chem. 263(14):6579-6587.
Lerner (1982) Nature 299:592-596.
Boyer (1986) "Modern Experimental Brochemistry", Addison-Wesley, Reading, Mass., pp. 534-535.
Hermodson et al. (1983) Methods Enzymol. 91:352-359.
Metzler (1977) "Biochemistry. The Chemical Reactions of Living Cells", Academic Press, New York, N.Y., p. 127.
Seltzer (1985) J. Chrom. 326:147-155.
McKerrow (1987, May 5) J. Biol. Chem. 262(13):5943.
Hibbs et al. (1985) J. Biol. Chem. 260(4):2493-2500.
Krutzsch Henry
Liotta Lance A.
Stetler-Stevenson William
The United States of America as represented by the Department of
Walsh Stephen G.
LandOfFree
Antigenic matrix metalloproteinase peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic matrix metalloproteinase peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic matrix metalloproteinase peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1191788